Шарон Меримс

Научные публикации

• Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions
• Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanoma
• Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib
• The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma
• Ex-vivo Skin Permeability Tests of Nanoparticles for Microscopy Imaging
• Physical properties of gold nanoparticles affect skin penetration via hair follicles
• Pityriasis rubra pilaris induced by PD-1 inhibitor nivolumab
• Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions
• Subcutaneous granuloma annulare mimicking dermatomyositis
• Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients
• SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
• Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective Study
• Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases
• Soluble SLAMF6 Receptor Induces Strong CD8⁺ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
• A Rapidly Expanding Ulcer in the Armpit of a 48-year-old Man: A Quiz
• Adoptive cell therapy: past, present and future
• Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBL
• Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
• Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic
• Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β
• Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells
• Human T cell crosstalk is induced by tumor membrane transfer
• Informal caregiving to older cancer patients: preliminary research outcomes and implications
• Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells
• Ctla-4 blockade: a new hope for the immunotherapy of malignant melanoma
• Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones
• HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine
• Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy
• Human Vδ1-T cells regulate immune responses by targeting autologous immature dendritic cells
• The validity of the Mathias criteria for establishing occupational causation and aggravation of contact dermatitis
• MHC class I-independent recognition of NK-activating receptor KIR2DS4
• Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma